Search for: "I.S. V. STATE"
Results 341 - 360
of 17,516
Sort by Relevance
|
Sort by Date
28 Jan 2024, 3:21 pm
See Bridges v. [read post]
28 Jan 2024, 8:10 am
It is established case law that Boards of Appeal are not obliged to explicitly state the reasons underlying a decision until they issue the final decision in writing. [read post]
28 Jan 2024, 6:26 am
A week from Thursday, on February 8, the Supreme Court will hear argument in No. 23-179, Trump v. [read post]
27 Jan 2024, 7:54 pm
[This post is co-authored with Professor Seth Barrett Tillman] On January 18, Professor Akhil Reed Amar and Professor Vikram Amar filed an amicus brief in Trump v. [read post]
27 Jan 2024, 4:31 am
Wallace v. [read post]
26 Jan 2024, 11:42 am
The most famous example of this blatant abuse came to a head in Castellanos v. [read post]
26 Jan 2024, 10:36 am
State v. [read post]
26 Jan 2024, 9:01 am
This would seem to be especially so in a case like the present one in light of the gap between “plausibility” and the particularly high standard that the Court has ruled applies before it will make a finding that a State is responsible for genocide – i.e., that for a pattern of conduct to be accepted as evidence of the existence of genocidal intent, it must be “the only inference that could reasonably be drawn from the acts in question. [read post]
26 Jan 2024, 8:45 am
Diedrich v. [read post]
25 Jan 2024, 9:36 am
Ark. 2019) (stating that “[t]he fact that the [confidentiality] Agreement does not state a time limitation, but instead applies forever, further supports a finding that it is unenforceable”); Howard Schultz & Assocs. v. [read post]
25 Jan 2024, 6:26 am
See Novak v. [read post]
24 Jan 2024, 3:40 am
In 2018, i.e. before the Santen decision from the CJEU, Merck applied to the UK IPO for an SPC for its medicinal product “MAVENCLAD”, which contains the active ingredient cladribine, for relapsing remitting multiple sclerosis. [read post]
23 Jan 2024, 8:53 am
Rapanos v. [read post]
23 Jan 2024, 2:32 am
On 19 December 2023, the Court of Appeal handed down its decision in The NOCO Company v Shenzhen Carku Technology Co., Ltd [2023] EWCA Civ 1502. [read post]
22 Jan 2024, 3:32 am
In post-1997 companies, the BCL expressly states that a shareholder does not have preemptive rights unless they are provided for in the corporation’s certificate of incorporation. [read post]
22 Jan 2024, 2:48 am
” (See Brownell v. [read post]
21 Jan 2024, 6:56 am
The scam is also 180 out from Lucian Grange’s call for artist centric royalty rates, so as a matter of policy it’s inconsistent with at least Universal’s stated goals. [read post]
21 Jan 2024, 6:00 am
The case is called O’Donnell v. [read post]
21 Jan 2024, 2:49 am
The description, as an integral part of the patent specification, should therefore also serve this overriding objective, i.e. it should provide a common understanding and interpretation of the claims. [read post]
19 Jan 2024, 10:59 am
It defines a direct cost as “any cost which is identified specifically with a particular final cost objective,” i.e., a contract.[27] Correspondingly, an indirect cost is “any cost not directly identified with a single final cost objective, but identified with two or more final cost objectives or with at least one intermediate objective. [read post]
